Concepedia

Vaishakhi Trivedi

VT

Statistics

Publications

12

Citations

833

H-Index

10

Active since

2014

Affiliations

Tata Memorial Hospital(Current)

Advanced Centre for Treatment, Research and Education in Cancer

Homi Bhabha National Institute

Vaishakhi Trivedi is an author at Tata Memorial Hospital specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2014–2023

12

Publications

12

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 421 citations

, , +15

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

Kanika Bajaj Pahuja, Thong Tien Nguyen, Bijay S. Jaiswal et al. · Cancer Cell · 2018 · 169 citations · Full text

, , +11

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Anuradha Choughule, Rashmi Sharma, Vaishakhi Trivedi et al. · British Journal of Cancer · 2014 · 45 citations · Full text

, , +16

&lt;p&gt;Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis&lt;/p&gt;

Shruti Kate, Anuradha Chougule, Amit Joshi et al. · Lung Cancer Targets and Therapy · 2019 · 40 citations · Full text

, , +12

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

Amit Joshi, Nikhil Pande, Vanita Noronha et al. · ecancermedicalscience · 2019 · 34 citations · Full text

, , +15

1–5 of 12